Filing Details
- Accession Number:
- 0001181431-11-057476
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-22 19:40:42
- Reporting Period:
- 2011-11-22
- Filing Date:
- 2011-11-22
- Accepted Time:
- 2011-11-22 19:40:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1411906 | Ampio Pharmaceuticals Inc. | AMPE | Pharmaceutical Preparations (2834) | 260179592 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1109775 | H Philip Coelho | C/O Ampio Pharmaceuticals, Inc. 5445 Dtc Parkway, Suite 925 Greenwood Village CO 80111 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-11-22 | 34,446 | $1.03 | 38,991 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-11-22 | 4,446 | $7.98 | 34,545 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2011-11-22 | 34,446 | $0.00 | 34,446 | $1.03 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
160,554 | 2010-08-12 | 2020-08-21 | No | 4 | M | Direct |
Footnotes
- On November 22, 2011, the reporting person exercised an option to purchase 34,446 shares of common stock of the Issuer for $1.03 per share. The reporting person paid the exercise price on a cashless basis, resulting the Issuer's withholding of 4,446 shares of common stock to pay the exercise price and issuing to the reporting person the remaining 30,000 shares of common stock.